Horizon / Plein textes La base de ressources documentaires de l'IRD

IRD

Publications des scientifiques de l'IRD

Barbosa A. N., Boyer L., Chippaux Jean-Philippe, Medolago N. B., Caramori C. A., Paixao A. G., Poli J. P. V., Mendes M. B., dos Santos L. D., Ferreira R. S., Barraviera B. (2017). A clinical trial protocol to treat massive Africanized honeybee (Apis mellifera) attack with a new apilic antivenom. Journal of Venomous Animals and Toxins Including Tropical Diseases, 23 (1), art. 14 [10 p.]. ISSN 1678-9199

Fichier PDF disponible http://horizon.documentation.ird.fr/exl-doc/pleins_textes/divers17-04/010069428.pdf

Lien direct chez l'éditeur doi:10.1186/s40409-017-0106-y

Titre
A clinical trial protocol to treat massive Africanized honeybee (Apis mellifera) attack with a new apilic antivenom
Année de publication2017
Type de documentArticle référencé dans le Web of Science WOS:000397663000001
AuteursBarbosa A. N., Boyer L., Chippaux Jean-Philippe, Medolago N. B., Caramori C. A., Paixao A. G., Poli J. P. V., Mendes M. B., dos Santos L. D., Ferreira R. S., Barraviera B.
SourceJournal of Venomous Animals and Toxins Including Tropical Diseases, 2017, 23 (1), p. art. 14 [10 p.]. p. art. 14 [10 p.] ISSN 1678-9199
RésuméBackground: Envenomation caused by multiple stings from Africanized honeybees Apis mellifera constitutes a public health problem in the Americas. In 2015, the Brazilian Ministry of Health reported 13,597 accidents (incidence of seven cases per 100,000 inhabitants) with 39 deaths (lethality of 0.25%). The toxins present in the venom, which include melittin and phospholipase A(2), cause lesions in diverse organs and systems that may be fatal. As there has been no specific treatment to date, management has been symptomatic and supportive only. Methods: In order to evaluate the safety and neutralizing capacity of a new apilic antivenom, as well as to confirm its lowest effective dose, a clinical protocol was developed to be applied in a multicenter, non-randomized and open phase I/II clinical trial. Twenty participants with more than five stings, aged more than 18 years, of both sexes, who have not previously received the heterologous serum against bee stings, will be included for 24 months. The proposed dose was based on the antivenom neutralizing capacity and the number of stings. Treatment will be administered only in a hospital environment and the participants will be evaluated for a period up to 30 days after discharge for clinical and laboratory follow-up. Results: This protocol, approved by the Brazilian regulatory agencies for ethics (National Commission for Ethics on Research-CONEP) and sanitation (National Health Surveillance Agency-ANVISA), is a guideline constituted by specific, adjuvant, symptomatic and complementary treatments, in addition to basic orientations for conducting a clinical trial involving heterologous sera. Conclusions: This is the first clinical trial protocol designed specifically to evaluate the preliminary efficacy and safety of a new antivenom against stings from the Africanized honeybee Apis mellifera. The results will support future studies to confirm a new treatment for massive bee attack that has a large impact on public health in the Americas.
Plan de classementSanté : généralités [050] ; Sciences du monde animal [080] ; Sciences fondamentales / Techniques d'analyse et de recherche [020]
Descr. géo.BRESIL
LocalisationFonds IRD [F B010069428]
Identifiant IRDfdi:010069428
Lien permanenthttp://www.documentation.ird.fr/hor/fdi:010069428

Export des données

Disponibilité des documents

Télechargment fichier PDF téléchargeable

Lien sur le Web lien chez l'éditeur

Accès réservé en accès réservé

HAL en libre accès sur HAL


Accès aux documents originaux :

Le FDI est labellisé CollEx

Accès direct

Bureau du chercheur

Site de la documentation

Espace intranet IST (accès réservé)

Suivi des publications IRD (accès réservé)

Mentions légales

Services Horizon

Poser une question

Consulter l'aide en ligne

Déposer une publication (accès réservé)

S'abonner au flux RSS

Voir les tableaux chronologiques et thématiques

Centres de documentation

Bondy

Montpellier (centre IRD)

Montpellier (MSE)

Nouméa

Papeete

Niamey

Ouagadougou

Tunis

La Paz

Quito